Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment.

Hsin-Wei Fang,Tsung-Hui Hu,Jing-Houng Wang,Chao-Hung Hung,Sheng-Nan Lu,Chien-Hung Chen

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver（2023）

引用 1|浏览13

暂无评分

摘要

The HBsAg loss rate was high and post-treatment HBsAg decline could predict high HBsAg loss rate among HBeAg-negative patients who discontinued entecavir or TDF and did not need retreatment.

查看译文

关键词

Entecavir,HBsAg,Hepatitis B virus,Tenofovir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要